LEADER 01838oam  2200493Ia 450 
001 9910697071903321
005 20230902162110.0
035   $a(CKB)5470000002384181
035   $a(OCoLC)729721563
035   $a(EXLCZ)995470000002384181
100   $a20110609d2009      ua             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aBuprenorphine$b[electronic resource] $ea guide for nurses /$f[prepared by Sara Azimi-Bolourian and Katherine Fornili]
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment,$d[2009]
215   $a1 online resource (vi, 104 pages) $cillustrations (some color)
225 1 $aDHHS publication ;$vno. (SMA) 09-4376
225 1 $aTechnical assistance publication series ;$v30
300   $aTitle from title screen (viewed June 8, 2011).
320   $aIncludes bibliographical references (pages 101-104).
410  0$aDHHS publication ;$vno. (SMA) 09-4376.
410  0$aTechnical assistance publication series ;$vno. 30.
517   $aBuprenorphine 
606   $aBuprenorphine$xTherapeutic use
606   $aNursing$vHandbooks, manuals, etc
606   $aOpioid abuse$xTreatment
608   $aHandbooks and manuals.$2lcgft
615  0$aBuprenorphine$xTherapeutic use.
615  0$aNursing
615  0$aOpioid abuse$xTreatment.
700   $aAzimi-Bolourian$b Sara$01409165
701   $aFornili$b Katherine$01409166
712 02$aAbt Associates.
712 02$aCenter for Substance Abuse Treatment (U.S.)
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910697071903321
996   $aBuprenorphine$93494887
997   $aUNINA